These results suggest that AKT-GSK3β-MYC oncogene addiction hypothesis is not involved in the synthetic lethality, but BETi-induced MYC inhibition still plays a key role in the synthetic lethality in PTEN-deficient CRC cells. This evidence concerns the gene AKT1 and colorectal carcinoma.